430 related articles for article (PubMed ID: 21242408)
1. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L
Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
[No Abstract] [Full Text] [Related]
2. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
Vergilis-Kalner IJ
J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Rosell K; Hymnelius K; Swartling C
Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
Naumann M; Lowe NJ
BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
[TBL] [Abstract][Full Text] [Related]
5. Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis.
Baumann LS; Halem ML
Arch Dermatol; 2003 Feb; 139(2):226-7. PubMed ID: 12588237
[No Abstract] [Full Text] [Related]
6. Treatment of axillary hyperhidrosis with botulinum-A toxin.
Salmanpoor R; Rahmanian MJ
Int J Dermatol; 2002 Jul; 41(7):428-30. PubMed ID: 12121560
[TBL] [Abstract][Full Text] [Related]
7. Writer's block: "texting" impairment as a complication of botulinum toxin type A therapy for palmar hyperhidrosis.
Lehman JS
Arch Dermatol; 2011 Jun; 147(6):752. PubMed ID: 21690551
[No Abstract] [Full Text] [Related]
8. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
[No Abstract] [Full Text] [Related]
10. How to save botulinum toxin A in the treatment of focal axillary hyperhidrosis.
Bechara FG; Sand M; Hoffmann K
Dermatology; 2006; 213(4):356. PubMed ID: 17135747
[No Abstract] [Full Text] [Related]
11. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
Naumann M; Lowe NJ; Kumar CR; Hamm H;
Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
[TBL] [Abstract][Full Text] [Related]
12. Inverse psoriasis and hyperhidrosis of the axillae responding to botulinum toxin type A.
Saber M; Brassard D; Benohanian A
Arch Dermatol; 2011 May; 147(5):629-30. PubMed ID: 21576592
[No Abstract] [Full Text] [Related]
13. [Management of axillary hyperhidrosis].
Pomarède N
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S125-8. PubMed ID: 19576478
[TBL] [Abstract][Full Text] [Related]
14. Commentary: Botulinum toxin in clinical medicine: part II.
Benedetto AV
Clin Dermatol; 2004; 22(1):1-2. PubMed ID: 15158537
[No Abstract] [Full Text] [Related]
15. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
Wynn RL
Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
[No Abstract] [Full Text] [Related]
16. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
[TBL] [Abstract][Full Text] [Related]
17. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
Güleç AT
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
[TBL] [Abstract][Full Text] [Related]
18. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
[TBL] [Abstract][Full Text] [Related]
19. Treatment of compensatory hyperhidrosis with botulinum toxin type A.
Belin EE; Polo J
Cutis; 2003 Jan; 71(1):68-70. PubMed ID: 12553633
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin in the treatment of axillary hyperhidrosis.
Galadari I; Alkaabi J
Skinmed; 2003; 2(4):209-11. PubMed ID: 14673273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
